tradingkey.logo


Progyny Inc

PGNY

22.545USD

-0.965-4.10%
āđ€āļ§āļĨāļēāļ—āļģāļāļēāļĢāļ•āļĨāļēāļ” ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
1.93BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
36.79P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Progyny Inc āļšāļĢāļīāļĐāļąāļ—
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PGNY
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Progyny Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 25, 2019
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2008
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Peter (Pete) Anevski
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™675
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Oct 25
āļ—āļĩāđˆāļ­āļĒāļđāđˆ1359 Broadway
āđ€āļĄāļ·āļ­āļ‡NEW YORK
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ Global Select Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ10018
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ12128883124
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.progyny.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™PGNY
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 25, 2019
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2008
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
248.40K
-3.11%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.87K
-1.53%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
19.73K
+68.59%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
14.11K
-15.93%
Mr. Mark S. Livingston
Mr. Mark S. Livingston
Chief Financial Officer
Chief Financial Officer
11.69K
-15.76%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
248.40K
-3.11%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Fertility benefits services revenue
206.41M
63.70%
Pharmacy benefits services revenue
117.63M
36.30%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
324.04M
100.00%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Fertility benefits services revenue
206.41M
63.70%
Pharmacy benefits services revenue
117.63M
36.30%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 8 āļĄāļī.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 8 āļĄāļī.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
12.86%
The Vanguard Group, Inc.
11.52%
Thrivent Asset Management, LLC
6.24%
Seidenberg (Beth C)
6.24%
Kleiner, Perkins, Caufield & Byers
5.92%
Other
57.23%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
12.86%
The Vanguard Group, Inc.
11.52%
Thrivent Asset Management, LLC
6.24%
Seidenberg (Beth C)
6.24%
Kleiner, Perkins, Caufield & Byers
5.92%
Other
57.23%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
52.38%
Investment Advisor/Hedge Fund
27.02%
Hedge Fund
7.86%
Individual Investor
7.62%
Venture Capital
5.93%
Research Firm
3.50%
Pension Fund
1.48%
Bank and Trust
0.40%
Family Office
0.09%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
751
92.33M
107.71%
-28.36M
2025Q1
761
91.24M
106.44%
-29.72M
2024Q4
736
97.21M
113.81%
-18.60M
2024Q3
721
97.59M
108.87%
-13.76M
2024Q2
700
102.42M
113.70%
-10.92M
2024Q1
684
101.40M
106.22%
-3.55M
2023Q4
667
98.10M
102.55%
-7.56M
2023Q3
653
97.93M
102.95%
-1.75M
2023Q2
657
95.12M
99.98%
-10.18M
2023Q1
644
96.30M
102.13%
-5.85M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
11.02M
12.86%
-941.22K
-7.87%
Mar 31, 2025
The Vanguard Group, Inc.
8.60M
10.03%
-74.17K
-0.86%
Mar 31, 2025
Thrivent Asset Management, LLC
5.35M
6.24%
+5.29M
+9244.37%
Mar 31, 2025
Seidenberg (Beth C)
5.35M
6.24%
+7.21K
+0.13%
May 23, 2024
Kleiner, Perkins, Caufield & Byers
5.07M
5.92%
--
--
Mar 28, 2025
State Street Global Advisors (US)
2.91M
3.4%
-223.01K
-7.11%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.87M
3.35%
+2.74M
+2093.50%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
2.21M
2.58%
+2.21M
--
Mar 31, 2025
Geode Capital Management, L.L.C.
1.80M
2.1%
-23.31K
-1.28%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.56M
1.82%
+909.48K
+139.26%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Alger Weatherbie Enduring Growth ETF
3.71%
Invesco S&P SmallCap 600 GARP ETF
2.44%
SPDR S&P Health Care Services ETF
2.07%
Invesco S&P SmallCap Health Care ETF
1.14%
First Trust Small Cap US Equity Select ETF
1.03%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.87%
VictoryShares Small Cap Free Cash Flow ETF
0.64%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.57%
Janus Henderson Small Cap Growth Alpha ETF
0.42%
First Trust Active Factor Small Cap ETF
0.37%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Alger Weatherbie Enduring Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.71%
Invesco S&P SmallCap 600 GARP ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.44%
SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.07%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.14%
First Trust Small Cap US Equity Select ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.03%
Pacer US Small Cap Cash Cows Growth Leaders ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.87%
VictoryShares Small Cap Free Cash Flow ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.64%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.57%
Janus Henderson Small Cap Growth Alpha ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.42%
First Trust Active Factor Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.37%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™